Social Media in the Management of Obesity and Diabetes: An Underutilised Population Educational Tool Frederick KeenBunny BhukyaLyndon M. Evans Commentary Open access 06 May 2024 Pages: 1255 - 1260
Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia–Pacific Region Roger ChenAzizul Hasan AamirRoopa Mehta Review Open access 16 April 2024 Pages: 1261 - 1277
Emerging Perspectives on the Impact of Diabetes Mellitus and Anti-Diabetic Drugs on Premenstrual Syndrome. A Narrative Review Omnia Azmy NabehAlaa AmrSoha Aly Elmorsy Review Open access 26 April 2024 Pages: 1279 - 1299
Associations Between HbA1c and Glucose Time in Range Using Continuous Glucose Monitoring in Type 1 Diabetes: Cross-Sectional Population-Based Study Björn EliassonElin Allansson KjölhedeKatarina Eeg-Olofsson Original Research Open access 10 April 2024 Pages: 1301 - 1312
Effectiveness, Simplification and Persistence of IDegLira in Poorly Controlled People with Type 2 Diabetes: A 4-Year Follow-Up Real-World Study Chiara Di LoretoRoberta CellenoPaola Del Sindaco Original Research Open access 11 April 2024 Pages: 1313 - 1331
Neutrophil Extracellular Traps (NETs) Are Associated with Type 2 Diabetes and Diabetic Foot Ulcer Related Amputation: A Prospective Cohort Study Irshat IbrahimYilimire NuermaimaitiYuanquan Wu Original Research Open access 15 April 2024 Pages: 1333 - 1348
Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study Pierre GourdyPatrice DarmonAlfred Penfornis Original Research Open access 20 April 2024 Pages: 1349 - 1360
Psychosocial Self-efficacy and its Association with Selected Potential Factors Among Adults with Type 1 Diabetes: A Cross-Sectional Survey Study Divya Anna StephenAnna NordinJan Nilsson Original Research Open access 20 April 2024 Pages: 1361 - 1373
Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years Daniel TajdarDagmar LühmannIngmar Schäfer Original Research Open access 20 April 2024 Pages: 1375 - 1388
Real-World Effectiveness of the Gla-300 + Cap + App Program in Adult Users Living with Type 2 Diabetes in Taiwan Chih-Yuan WangFang L. ZhouJung-Fu Chen Original Research Open access 20 April 2024 Pages: 1389 - 1401
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study) Masahiro FukudaIchiro Sakumaon behalf of the J-SELECT study investigators Original Research Open access 24 April 2024 Pages: 1403 - 1416
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy Francesco Saverio MenniniPaolo SciattellaUgo Trama Original Research Open access 26 April 2024 Pages: 1417 - 1434
Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis Rachel S. NewsonVictoria DivinoJulie E. Mount Original Research Open access 29 April 2024 Pages: 1435 - 1449
Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study Dagoberto Serpa-DíazCarlos A. Llanos-FlorezMaria A. Alzate-Vinasco Original Research Open access 30 April 2024 Pages: 1451 - 1460
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol Peter NovodvorskýLenka ThiemeMartin Haluzík Study Protocol Open access 24 April 2024 Pages: 1461 - 1471
Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump Terri JerkinsKatherine StockhamDavid S. H. Bell Case Report Open access 24 April 2024 Pages: 1473 - 1481
Correction to: Use of IDegLira to Intensify, Simplify, and Increase Appropriateness of Type 2 Diabetes Therapy: A Real-Life Experience Isabella RomanoRosalia Serra Correction Open access 18 April 2024 Pages: 1483 - 1483
Correction to: Effect of Neo-Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD Giuseppina GuarinoFelice StrolloSandro Gentile Correction Open access 22 April 2024 Pages: 1485 - 1490